Olema Pharmaceuticals (OLMA) Treasury Shares (2020 - 2026)
Olema Pharmaceuticals' (OLMA) quarterly Treasury Shares came in at $402807.0 in Q1 2026, little changed on a QoQ basis from $403000.0 in Q3 2024.
Olema Pharmaceuticals (OLMA) Treasury Shares (2020 - 2026) Analysis & Trends
Olema Pharmaceuticals (OLMA) has 6 years of Treasury Shares data on file, last reported at $402807.0 in Q1 2026.
- On a quarterly basis, Treasury Shares changed N/A year-over-year to $402807.0 in Q1 2026; TTM through Mar 2026 was $402807.0, a N/A change from a year earlier, with the FY2023 full-year figure at $403000.0, down 43.24% from the prior year.
- Treasury Shares for Q1 2026 stood at $402807.0, roughly flat from $403000.0 in the prior quarter.
- Over the last five years, Treasury Shares for OLMA reached as high as $710000.0 in Q4 2022 and fell as low as $40352.0 in Q1 2024.
- Historically, Treasury Shares has averaged $339511.5 across 4 years, with a median of $394548.0 in 2022.
- On a YoY basis, Treasury Shares climbed as much as 172.38% in 2024 and fell as far as 83.64% in 2024.
- Year by year, Treasury Shares stood at $710000.0 in 2022, then slumped by 43.24% to $403000.0 in 2023, then changed by 0.0% to $403000.0 in 2024, then retreated by 0.05% to $402807.0 in 2026.
- Per Business Quant data, the three most recent Treasury Shares figures were $402807.0 in Q1 2026, $403000.0 in Q3 2024, and $40352.0 in Q1 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Olema Pharmaceuticals | 1.21 Bn | 1.21 Bn | - | 402,807.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 402,807.00 |
| Mar 31, 2026 | 402,807.00 |
| Sep 30, 2024 | 403,000.00 |
| Sep 30, 2024 | 403,000.00 |
| Mar 31, 2024 | 40,352.00 |
| Mar 31, 2024 | 40,352.00 |
| Dec 31, 2023 | 403,000.00 |
| Dec 31, 2023 | 403,000.00 |
| Sep 30, 2023 | 147,956.00 |
| Sep 30, 2023 | 147,956.00 |
| Jun 30, 2023 | 197,274.00 |
| Jun 30, 2023 | 197,274.00 |
| Mar 31, 2023 | 246,593.00 |
| Mar 31, 2023 | 246,593.00 |
| Dec 31, 2022 | 710,000.00 |
| Dec 31, 2022 | 710,000.00 |
| Sep 30, 2022 | 345,230.00 |
| Sep 30, 2022 | 345,230.00 |
| Jun 30, 2022 | 394,548.00 |
| Jun 30, 2022 | 394,548.00 |